An interventional study of Medical yoga in Cancer, sponsored by Linkoeping University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Linkoeping University · Not applicable, Interventional, and Device feasibility
The project aims to develop a gamified medical yoga intervention through co-design with patients with cancer and key stakeholders, ensuring alignment with user needs and requirements. The first objective is to identify user and stakeholder needs, preferences, and requirements for effective home-based training. The project will then examine facilitators and barriers that influence patient engagement with gamification interventions. Subsequently, it will assess the feasibility, acceptability, including usability and acceptability, of the gamified AI yoga intervention for patients with cancer in real-world implementation contexts.
9,610 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.
This study's planned enrollment of 10 is below the median of 50 across 7,429 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Linkoeping University is the lead sponsor of 193 studies on the registry; 41 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Feasability of using a yoga application for 2 months
Device: Medical yoga
Feasability testina a gamified yoga application for 2 months
Device feasability
Acceptability and usabilitywill be explored through semi-structured interviews. Interview data will be analyzed using qualitative content analysis to identify themes related to participants' experiences, perceived benefits, barriers, and suggestions for improvement.
Time frame: from enrollment and after 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Dec 2028, 27 months after the start.
Of 1,358 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 71. This study's planned 27 months is below that.
Counting every sponsor, half of 1,404 studies reached it within 38 months; a quarter within 17 and three quarters within 71.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.